Unlock instant, AI-driven research and patent intelligence for your innovation.

Modified human immunodeficiency virus membrane protein and application thereof

A technology of recombinant protein and furin, which is applied in the direction of antiviral immunoglobulin, virus, viral peptide, etc., can solve the problems of HIV-1 irreversibility, loss of pathogenic infection ability, etc., and achieve uniform composition, three The effect of increasing the polymer content and improving thermal stability

Pending Publication Date: 2022-05-13
XIAMEN UNIV +1
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the pathogenicity and irreversibility of HIV-1, attenuated or inactivated HIV-1 vaccines have the potential risk of infecting the human body, which limits the application of HIV-1 inactivated or attenuated viruses in the development of AIDS vaccines. It is a very novel and safe vaccine design idea to prepare an HIV-1 virus vaccine that has completely lost its pathogenicity and cannot regain its infectivity through reverse mutation after transformation. It is a very novel and safe vaccine design idea. A breakthrough in the field of AIDS vaccine research and development

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Modified human immunodeficiency virus membrane protein and application thereof
  • Modified human immunodeficiency virus membrane protein and application thereof
  • Modified human immunodeficiency virus membrane protein and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0204] Embodiment 1: Expression of TSTIP protein of two strains of NL4-3 / BG505

[0205] 4-3 / BG505 TSTIP modification design

[0206]The base and amino acid sequences of the two strains BG505 / pNL4-3-gp160 on NCBI were used as templates for transformation. Taking the transformation of BG505 as an example, according to the three-dimensional cryo-electron microscope structure of BG505-SOSIP (PDB: 4tvp), part of the loop sequence (aa610-616, WNSSWSN) at the C-terminal of β27 of BG505 gp41 was removed, and the C-terminal of gp120 including furin enzyme The sequence of 10 amino acids including the cleavage site (aa501-511, AKRRVVGREKR). The truncated C-terminus of β27 of gp41 was then linked to the N-terminus of gp120, and the truncated C-terminus of gp120 was linked to the N-terminus of the α8 domain of gp41. The amino acid sequence of the modified complete gp140 is as follows: α6 / α7 / β27 (501-606) + part of the loop region between β27 and α8 (607-609) + gp120 (33-500) + the loop...

Embodiment 2

[0216] Embodiment 2: NL4-3 / BG505 TSTIP protein purification

[0217] After 6 days of transient transfection, collect the cell culture medium, centrifuge at 7000g for 10 minutes with JA-14 rotor, take the cell supernatant, centrifuge at 20000g for 10 minutes, take the supernatant and filter it twice with a 0.22um pore size filter membrane, and use this sample for the next step of Ni-excel Column purification.

[0218] Purification by Ni affinity chromatography using the AKTA system;

[0219] Instrument system: AKTA Pure preparative liquid chromatograph;

[0220] Purification medium: Ni Sepharose excel affinity medium; buffer: divided into A and B buffer, A solution is 1×PBS buffer, B pump is 1×PBS+250mmol / L imidazole buffer;

[0221] System sample flow rate: 8mL / min; detection wavelength: UV@280nm

[0222] System elution flow rate: 4ml / min; detection wavelength: UV@280nm

[0223] Elution conditions: 20mM imidazole was used to elute the impurity protein, and the 250mM imidaz...

Embodiment 3

[0224] Example 3: Identification of biochemical properties of NL4-3 / BG505 TSTIP protein

[0225] SDS-PAGE:

[0226] Dilute the concentrated sample and BG505 / 4-3SOSIP protein in Example 2 to 1ug / ul, take two tubes of 50ul samples, add 10ul reduced 6Loading Buffer and 10ul non-reduced 6Loading Buffer respectively, prepare reduced samples and non-reduced samples, reduced samples In a boiling water bath at 100°C for 10 minutes. Take 10ul of the reduced and non-reduced samples and electrophoresis at 80V for 120min in 8% SDS-PAGE. After staining with Coomassie brilliant blue, the electrophoresis bands are displayed. For the electrophoresis results, see Figure 2A-2B . SDS-PAGE analysis shows that after one-step Ni-EXCEL purification, high-purity BG505 / NL4-3TSTIP protein can be obtained, and the TSTIP protein is a complete 140KD band in the presence of DTT, while the BG505 / NL4-3SOSIP protein is under reducing conditions A 120KD band appeared, indicating that the protein designed...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Wavelengthaaaaaaaaaa
Login to View More

Abstract

The invention relates to an HIV-1 Env trimer protein which is newly designed, an HIV-1 pseudovirus and an HIV-1 true virus which express the Env trimer protein, and application of the HIV-1 pseudovirus and the HIV-1 true virus to prevention and / or treatment of HIV infection.

Description

technical field [0001] The present invention relates to the field of virology. Specifically, the present invention relates to a newly designed HIV-1 Env trimer protein and HIV-1 pseudoviruses and true viruses expressing said Env trimer protein, and their use in preventing and / or treating HIV infection the use of. Background technique [0002] Human immunodeficiency virus type 1 HIV-1 (Human immunodeficiency virus-1) is the main pathogen that induces AIDS. Composed of stranded RNA, the single-stranded genome is about 9.8kb, which encodes three structural proteins Env, Gag, Pol and six auxiliary proteins: vpr, vif, vpu, nef, tat, rev. Accessory proteins coordinate with each other to form a regulatory network for HIV-1 viral replication. The Pol gene encodes the polymerase precursor protein, which forms protease (PR), reverse transcriptase (RT) and integrase (IN) after cleavage, which are key enzymes for virus maturation, replication and infection. The Gag protein encoded b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K19/00C12N7/01A61K39/21A61K45/06A61P31/18C12R1/93
CPCC07K14/005C12N7/00A61K39/12A61K45/06A61P31/18C12N2740/16122C07K2319/00C07K2319/03C12N2740/16021C12N2740/16034A61K2039/53A61K2300/00C12N2710/00C07K16/1063C07K2317/76C12N2740/16134A61K2039/575C12N15/86C12N2740/16043C07K16/10A61K39/21A61K2039/5258A61K2039/645C07K2319/40C12N2740/16171
Inventor 顾颖邓婷婷张慧黄芳陈格格林燕玲李少伟夏宁邵
Owner XIAMEN UNIV